Again in July, FDA Rejects Indian Shrimp for Antibiotic Contamination and Salmonella

The U.S. Food and Drug Administration (FDA) has released information regarding import refusals in July reporting that 2 out of the 157 (1.3%) total seafood entry line refusals last month were of shrimp for reasons related to banned antibiotics.
This was the lowest number of entry lines refused for antibiotic contamination this year. Through July, there have been a total of 27 shrimp entry lines refused for reasons related to banned antibiotics:
The two shrimp entry line refusals in July were from exporters in two different countries – India and China:
  • Savvy Seafood Inc. (China), a company that has lost its exemption from Import Alert 16-131 (“Detention Without Physical Examination of Aquacultured Shrimp, Dace, and Eel from China – Presence of New Animal Drugs and/or Unsafe Food Additives”), hadone entry line refused for breaded shrimp contaminated with veterinary drug residues and unsafe additives by the Division of Southeast Imports on July 6, 2018; and
  •  Nekkanti Sea Foods Limited (India), a company that was added to Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) on July 30, 2018, had one entry line refused for shrimp contaminated with veterinary drug residues by the Division of Southeast Imports on July 20, 2018.
Further, the FDA reported refusing another ten shrimp entry lines for salmonella in July, of which eight were from India. While the total number of shrimp entry lines refused for veterinary drug residues has declined in 2018, the FDA has now reported refusing 60 entry lines of shrimp for salmonella this year, of which the vast majority originate from India.

Filed Under